China Resources Sanjiu Medical & Pharmaceutical Co Ltd (000999) — Cash Flow Reinvestment Rate
China Resources Sanjiu Medical & Pharmaceutical Co Ltd (000999) has a Cash Flow Reinvestment Rate of 2.38x as of September 2025, reinvesting CN¥302.02 Million (capex CN¥302.02 Million ) from operating cash flow of CN¥126.71 Million. Explore 000999 capital reinvestment ratio to see what proportion of operating cash flow is directed to capital expenditures.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
China Resources Sanjiu Medical & Pharmaceutical Co Ltd Cash Flow Reinvestment Rate (1999–2024)
Historical reinvestment intensity for China Resources Sanjiu Medical & Pharmaceutical Co Ltd across 25 annual periods. Also explore balance sheet size of China Resources Sanjiu Medical & Pharmac for the complete picture of this company's asset base.
Annual Cash Flow Reinvestment Rate for China Resources Sanjiu Medical & Pharmaceutical Co Ltd (1999–2024)
Year-by-year capital reinvestment analysis for China Resources Sanjiu Medical & Pharmaceutical Co Ltd. For live market cap and broader valuation context, see 000999 stock market capitalisation.
| Year | Reinvestment Rate | Total Reinvested (CNY) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2024 | 0.24x | CN¥1.04 Billion | CN¥4.40 Billion | CN¥790.07 Million | ▼ -39.9% |
| 2023 | 0.39x | CN¥1.65 Billion | CN¥4.22 Billion | CN¥857.21 Million | ▼ -65.7% |
| 2022 | 1.14x | CN¥3.43 Billion | CN¥3.01 Billion | CN¥951.57 Million | ▲ +22.6% |
| 2021 | 0.93x | CN¥1.74 Billion | CN¥1.87 Billion | CN¥870.80 Million | ▲ +47.4% |
| 2020 | 0.63x | CN¥1.40 Billion | CN¥2.22 Billion | CN¥621.82 Million | ▲ +89.3% |
| 2019 | 0.33x | CN¥657.49 Million | CN¥1.97 Billion | CN¥535.97 Million | ▼ -22.3% |
| 2018 | 0.43x | CN¥820.07 Million | CN¥1.91 Billion | CN¥600.36 Million | ▼ -13.6% |
| 2017 | 0.50x | CN¥774.84 Million | CN¥1.56 Billion | CN¥374.74 Million | ▼ -56.2% |
| 2016 | 1.13x | CN¥1.58 Billion | CN¥1.39 Billion | CN¥354.33 Million | ▲ +58.3% |
| 2015 | 0.72x | CN¥902.16 Million | CN¥1.26 Billion | CN¥330.65 Million | ▲ +148.6% |
| 2014 | 0.29x | CN¥341.22 Million | CN¥1.18 Billion | CN¥341.22 Million | ▲ +19.1% |
| 2013 | 0.24x | CN¥354.89 Million | CN¥1.47 Billion | CN¥354.89 Million | ▼ -41.9% |
| 2012 | 0.42x | CN¥504.52 Million | CN¥1.21 Billion | CN¥504.52 Million | ▼ -3.0% |
| 2011 | 0.43x | CN¥409.79 Million | CN¥954.90 Million | CN¥409.79 Million | ▲ +34.8% |
| 2010 | 0.32x | CN¥270.00 Million | CN¥848.28 Million | CN¥270.00 Million | ▲ +41.1% |
| 2009 | 0.23x | CN¥192.93 Million | CN¥855.05 Million | CN¥192.93 Million | ▼ -79.1% |
| 2008 | 1.08x | CN¥1.20 Billion | CN¥1.12 Billion | CN¥1.20 Billion | ▲ +187.7% |
| 2007 | 0.37x | CN¥226.78 Million | CN¥605.30 Million | CN¥226.78 Million | ▲ +17.4% |
| 2006 | 0.32x | CN¥135.81 Million | CN¥425.51 Million | CN¥135.81 Million | ▼ -80.4% |
| 2005 | 1.63x | CN¥37.14 Million | CN¥22.83 Million | CN¥37.14 Million | ▼ -66.4% |
| 2003 | 4.84x | CN¥135.88 Million | CN¥28.09 Million | CN¥135.88 Million | ▲ +1289.6% |
| 2002 | 0.35x | CN¥172.67 Million | CN¥496.12 Million | CN¥172.67 Million | ▼ -55.1% |
| 2001 | 0.77x | CN¥118.83 Million | CN¥153.44 Million | CN¥118.83 Million | ▲ +21.2% |
| 2000 | 0.64x | CN¥170.58 Million | CN¥266.86 Million | CN¥170.58 Million | ▲ +5.0% |
| 1999 | 0.61x | CN¥73.43 Million | CN¥120.63 Million | CN¥73.43 Million | — |